Table of Content

1 Drug Closed System Transmission Market Overview
1.1 Product Overview and Scope of Drug Closed System Transmission
1.2 Drug Closed System Transmission Segment by Type
1.2.1 Global Drug Closed System Transmission Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Closed Vial Access Device
1.2.3 Closed Syringe Safety Device
1.2.4 Closed Bag/Line Access Device
1.3 Drug Closed System Transmission Segment by Application
1.3.1 Drug Closed System Transmission Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Drug Closed System Transmission Market Size Estimates and Forecasts
1.4.1 Global Drug Closed System Transmission Revenue 2016-2027
1.4.2 Global Drug Closed System Transmission Sales 2016-2027
1.4.3 Drug Closed System Transmission Market Size by Region: 2016 Versus 2021 Versus 2027

2 Drug Closed System Transmission Market Competition by Manufacturers
2.1 Global Drug Closed System Transmission Sales Market Share by Manufacturers (2016-2021)
2.2 Global Drug Closed System Transmission Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Drug Closed System Transmission Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Drug Closed System Transmission Manufacturing Sites, Area Served, Product Type
2.5 Drug Closed System Transmission Market Competitive Situation and Trends
2.5.1 Drug Closed System Transmission Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug Closed System Transmission Players Market Share by Revenue
2.5.3 Global Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Drug Closed System Transmission Retrospective Market Scenario by Region
3.1 Global Drug Closed System Transmission Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Drug Closed System Transmission Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Drug Closed System Transmission Market Facts & Figures by Country
3.3.1 North America Drug Closed System Transmission Sales by Country
3.3.2 North America Drug Closed System Transmission Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Drug Closed System Transmission Market Facts & Figures by Country
3.4.1 Europe Drug Closed System Transmission Sales by Country
3.4.2 Europe Drug Closed System Transmission Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug Closed System Transmission Market Facts & Figures by Region
3.5.1 Asia Pacific Drug Closed System Transmission Sales by Region
3.5.2 Asia Pacific Drug Closed System Transmission Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Drug Closed System Transmission Market Facts & Figures by Country
3.6.1 Latin America Drug Closed System Transmission Sales by Country
3.6.2 Latin America Drug Closed System Transmission Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug Closed System Transmission Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug Closed System Transmission Sales by Country
3.7.2 Middle East and Africa Drug Closed System Transmission Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Drug Closed System Transmission Historic Market Analysis by Type
4.1 Global Drug Closed System Transmission Sales Market Share by Type (2016-2021)
4.2 Global Drug Closed System Transmission Revenue Market Share by Type (2016-2021)
4.3 Global Drug Closed System Transmission Price by Type (2016-2021)

5 Global Drug Closed System Transmission Historic Market Analysis by Application
5.1 Global Drug Closed System Transmission Sales Market Share by Application (2016-2021)
5.2 Global Drug Closed System Transmission Revenue Market Share by Application (2016-2021)
5.3 Global Drug Closed System Transmission Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Equashield
6.1.1 Equashield Corporation Information
6.1.2 Equashield Description and Business Overview
6.1.3 Equashield Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Equashield Product Portfolio
6.1.5 Equashield Recent Developments/Updates
6.2 BD Medical
6.2.1 BD Medical Corporation Information
6.2.2 BD Medical Description and Business Overview
6.2.3 BD Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021)
6.2.4 BD Medical Product Portfolio
6.2.5 BD Medical Recent Developments/Updates
6.3 Teva Medical
6.3.1 Teva Medical Corporation Information
6.3.2 Teva Medical Description and Business Overview
6.3.3 Teva Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teva Medical Product Portfolio
6.3.5 Teva Medical Recent Developments/Updates
6.4 ICU Medical
6.4.1 ICU Medical Corporation Information
6.4.2 ICU Medical Description and Business Overview
6.4.3 ICU Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021)
6.4.4 ICU Medical Product Portfolio
6.4.5 ICU Medical Recent Developments/Updates
6.5 Corvida Medical
6.5.1 Corvida Medical Corporation Information
6.5.2 Corvida Medical Description and Business Overview
6.5.3 Corvida Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Corvida Medical Product Portfolio
6.5.5 Corvida Medical Recent Developments/Updates
6.6 B. Braun
6.6.1 B. Braun Corporation Information
6.6.2 B. Braun Description and Business Overview
6.6.3 B. Braun Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021)
6.6.4 B. Braun Product Portfolio
6.6.5 B. Braun Recent Developments/Updates

7 Drug Closed System Transmission Manufacturing Cost Analysis
7.1 Drug Closed System Transmission Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug Closed System Transmission
7.4 Drug Closed System Transmission Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug Closed System Transmission Distributors List
8.3 Drug Closed System Transmission Customers

9 Drug Closed System Transmission Market Dynamics
9.1 Drug Closed System Transmission Industry Trends
9.2 Drug Closed System Transmission Growth Drivers
9.3 Drug Closed System Transmission Market Challenges
9.4 Drug Closed System Transmission Market Restraints

10 Global Market Forecast
10.1 Drug Closed System Transmission Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug Closed System Transmission by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Drug Closed System Transmission by Type (2022-2027)
10.2 Drug Closed System Transmission Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug Closed System Transmission by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Drug Closed System Transmission by Application (2022-2027)
10.3 Drug Closed System Transmission Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug Closed System Transmission by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Drug Closed System Transmission by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Drug Closed System Transmission Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Drug Closed System Transmission Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Drug Closed System Transmission Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Drug Closed System Transmission Covered in This Study
Table 5. Global Drug Closed System Transmission Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Drug Closed System Transmission Sales Share by Manufacturers (2016-2021)
Table 7. Global Drug Closed System Transmission Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Drug Closed System Transmission Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Drug Closed System Transmission Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Drug Closed System Transmission Manufacturing Sites and Area Served
Table 11. Manufacturers Drug Closed System Transmission Product Type
Table 12. Global Drug Closed System Transmission Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drug Closed System Transmission by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Closed System Transmission as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drug Closed System Transmission Sales by Region (2016-2021) & (K Units)
Table 16. Global Drug Closed System Transmission Sales Market Share by Region (2016-2021)
Table 17. Global Drug Closed System Transmission Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Drug Closed System Transmission Sales by Country (2016-2021) & (K Units)
Table 19. North America Drug Closed System Transmission Sales Market Share by Country (2016-2021)
Table 20. North America Drug Closed System Transmission Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Drug Closed System Transmission Revenue Market Share by Country (2016-2021)
Table 22. Europe Drug Closed System Transmission Sales by Country (2016-2021) & (K Units)
Table 23. Europe Drug Closed System Transmission Sales Market Share by Country (2016-2021)
Table 24. Europe Drug Closed System Transmission Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Drug Closed System Transmission Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Drug Closed System Transmission Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Drug Closed System Transmission Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Drug Closed System Transmission Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Drug Closed System Transmission Revenue Market Share by Region (2016-2021)
Table 30. Latin America Drug Closed System Transmission Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Drug Closed System Transmission Sales Market Share by Country (2016-2021)
Table 32. Latin America Drug Closed System Transmission Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Drug Closed System Transmission Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Drug Closed System Transmission Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Drug Closed System Transmission Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Drug Closed System Transmission Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Drug Closed System Transmission Revenue Market Share by Country (2016-2021)
Table 38. Global Drug Closed System Transmission Sales (K Units) by Type (2016-2021)
Table 39. Global Drug Closed System Transmission Sales Market Share by Type (2016-2021)
Table 40. Global Drug Closed System Transmission Revenue (Million US$) by Type (2016-2021)
Table 41. Global Drug Closed System Transmission Revenue Share by Type (2016-2021)
Table 42. Global Drug Closed System Transmission Price (US$/Unit) by Type (2016-2021)
Table 43. Global Drug Closed System Transmission Sales (K Units) by Application (2016-2021)
Table 44. Global Drug Closed System Transmission Sales Market Share by Application (2016-2021)
Table 45. Global Drug Closed System Transmission Revenue (Million US$) by Application (2016-2021)
Table 46. Global Drug Closed System Transmission Revenue Share by Application (2016-2021)
Table 47. Global Drug Closed System Transmission Price (US$/Unit) by Application (2016-2021)
Table 48. Equashield Corporation Information
Table 49. Equashield Description and Business Overview
Table 50. Equashield Drug Closed System Transmission Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Equashield Drug Closed System Transmission Product
Table 52. Equashield Recent Developments/Updates
Table 53. BD Medical Corporation Information
Table 54. BD Medical Description and Business Overview
Table 55. BD Medical Drug Closed System Transmission Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. BD Medical Drug Closed System Transmission Product
Table 57. BD Medical Recent Developments/Updates
Table 58. Teva Medical Corporation Information
Table 59. Teva Medical Description and Business Overview
Table 60. Teva Medical Drug Closed System Transmission Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Teva Medical Drug Closed System Transmission Product
Table 62. Teva Medical Recent Developments/Updates
Table 63. ICU Medical Corporation Information
Table 64. ICU Medical Description and Business Overview
Table 65. ICU Medical Drug Closed System Transmission Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. ICU Medical Drug Closed System Transmission Product
Table 67. ICU Medical Recent Developments/Updates
Table 68. Corvida Medical Corporation Information
Table 69. Corvida Medical Description and Business Overview
Table 70. Corvida Medical Drug Closed System Transmission Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Corvida Medical Drug Closed System Transmission Product
Table 72. Corvida Medical Recent Developments/Updates
Table 73. B. Braun Corporation Information
Table 74. B. Braun Description and Business Overview
Table 75. B. Braun Drug Closed System Transmission Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. B. Braun Drug Closed System Transmission Product
Table 77. B. Braun Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Drug Closed System Transmission Distributors List
Table 81. Drug Closed System Transmission Customers List
Table 82. Drug Closed System Transmission Market Trends
Table 83. Drug Closed System Transmission Growth Drivers
Table 84. Drug Closed System Transmission Market Restraints
Table 85. Global Drug Closed System Transmission Sales Forecast by Type (2022-2027) & (K Units)
Table 86. Global Drug Closed System Transmission Sales Market Share Forecast by Type (2022-2027)
Table 87. Global Drug Closed System Transmission Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 88. Global Drug Closed System Transmission Revenue Market Share Forecast by Type (2022-2027)
Table 89. Global Drug Closed System Transmission Sales Forecast by Application (2022-2027) & (K Units)
Table 90. Global Drug Closed System Transmission Sales Market Share Forecast by Application (2022-2027)
Table 91. Global Drug Closed System Transmission Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 92. Global Drug Closed System Transmission Revenue Market Share Forecast by Application (2022-2027)
Table 93. Global Drug Closed System Transmission Sales Forecast by Region (2022-2027) & (K Units)
Table 94. Global Drug Closed System Transmission Sales Market Share Forecast by Region (2022-2027)
Table 95. Global Drug Closed System Transmission Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 96. Global Drug Closed System Transmission Revenue Market Share Forecast by Region (2022-2027)
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Closed System Transmission
Figure 2. Global Drug Closed System Transmission Market Share by Type in 2020 & 2027
Figure 3. Closed Vial Access Device Product Picture
Figure 4. Closed Syringe Safety Device Product Picture
Figure 5. Closed Bag/Line Access Device Product Picture
Figure 6. Global Drug Closed System Transmission Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Drug Closed System Transmission Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Drug Closed System Transmission Market Size 2016-2027 (US$ Million)
Figure 12. Global Drug Closed System Transmission Sales 2016-2027 (K Units)
Figure 13. Global Drug Closed System Transmission Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Drug Closed System Transmission Sales Share by Manufacturers in 2020
Figure 15. Global Drug Closed System Transmission Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Drug Closed System Transmission Players: Market Share by Revenue in 2020
Figure 17. Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Drug Closed System Transmission Sales Market Share by Region (2016-2021)
Figure 19. Global Drug Closed System Transmission Sales Market Share by Region in 2020
Figure 20. Global Drug Closed System Transmission Revenue Market Share by Region (2016-2021)
Figure 21. Global Drug Closed System Transmission Revenue Market Share by Region in 2020
Figure 22. U.S. Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Drug Closed System Transmission by Type (2016-2021)
Figure 47. Sales Market Share of Drug Closed System Transmission by Application (2016-2021)
Figure 48. Sales Market Share of Drug Closed System Transmission by Application in 2020
Figure 49. Revenue Share of Drug Closed System Transmission by Application (2016-2021)
Figure 50. Revenue Share of Drug Closed System Transmission by Application in 2020
Figure 51. Manufacturing Cost Structure of Drug Closed System Transmission
Figure 52. Manufacturing Process Analysis of Drug Closed System Transmission
Figure 53. Drug Closed System Transmission Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed